• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vimentin in human erythroleukemia (HEL) cells is modulated with differentiation inducers.

作者信息

Järvinen M

机构信息

Department of Anatomy, University of Helsinki, Finland.

出版信息

Cell Biol Int Rep. 1990 Mar;14(3):199-209. doi: 10.1016/s0309-1651(05)80002-5.

DOI:10.1016/s0309-1651(05)80002-5
PMID:2188740
Abstract

The expression of vimentin intermediate filaments (IFs) was studied in a human erythroleukemia cell line (HEL), exposed to a variety of differentiation-inducing agents. These cells grow normally in suspension and show a heterogenous expression of vimentin immunoreactivity. In the presence of retinoic acid the fibrillar vimentin immunoreactivity diminished rapidly, while it was increased when the cells were exposed to hemin or butyric acid. In the presence of a tumor promoter (TPA), the HEL cells maintained their heterogenous vimentin immunoreactivity, but some cells showed large bundles of cytoplasmic vimentin fibrils. Upon exposure to TPA the cells spread on a growth substratum covered with human plasma fibronectin (Fn). Many of the spread cells totally lacked vimentin IFs. The present results show that vimentin expression in HEL cells is rapidly and differentially modulated upon exposure to the different inducing agents.

摘要

相似文献

1
Vimentin in human erythroleukemia (HEL) cells is modulated with differentiation inducers.
Cell Biol Int Rep. 1990 Mar;14(3):199-209. doi: 10.1016/s0309-1651(05)80002-5.
2
K562 erythroleukemia cells express cytokeratins 8, 18, and 19 and epithelial membrane antigen that disappear after induced differentiation.
J Cell Physiol. 1990 May;143(2):310-20. doi: 10.1002/jcp.1041430215.
3
Tumor promoter and fibronectin induce actin stress fibers and focal adhesion sites in spreading human erythroleukemia (HEL) cells.肿瘤启动子和纤连蛋白可诱导正在铺展的人红白血病(HEL)细胞中形成肌动蛋白应激纤维和粘着斑。
Eur J Cell Biol. 1987 Oct;44(2):238-46.
4
Remodeling of vimentin cytoskeleton correlates with enhanced motility of promyelocytic leukemia cells during differentiation induced by retinoic acid.波形蛋白细胞骨架的重塑与维甲酸诱导分化过程中早幼粒细胞白血病细胞运动性增强相关。
Anticancer Res. 2001 Nov-Dec;21(6A):3973-80.
5
Induction of differentiation of the human histiocytic lymphoma cell line U937 in the absence of vimentin expression.在缺乏波形蛋白表达的情况下诱导人组织细胞淋巴瘤细胞系U937分化。
Differentiation. 1990 Oct;45(1):55-60. doi: 10.1111/j.1432-0436.1990.tb00457.x.
6
Erythroleukemia cell lines HEL and K-562: changes in isoenzyme profiles and morphology during induction of differentiation.
Hematol Oncol. 1986 Apr-Jun;4(2):163-74. doi: 10.1002/hon.2900040208.
7
Differentiation of murine erythroleukemia cells results in the rapid repression of vimentin gene expression.小鼠红白血病细胞的分化导致波形蛋白基因表达的快速抑制。
J Cell Biol. 1984 Jul;99(1 Pt 1):306-14. doi: 10.1083/jcb.99.1.306.
8
Ultrastructural analysis of cytoplasmic intermediate filaments and the nuclear lamina in the mouse plasmacytoma cell line MPC-11 after the induction of vimentin synthesis.诱导波形蛋白合成后小鼠浆细胞瘤细胞系MPC - 11中细胞质中间丝和核纤层的超微结构分析
Eur J Cell Biol. 1989 Dec;50(2):462-74.
9
The effect of differentiation inducers on the integrin expression of K562 erythroleukemia cells.分化诱导剂对K562红白血病细胞整合素表达的影响。
Cell Biol Int. 1993 Apr;17(4):399-407. doi: 10.1006/cbir.1993.1078.
10
Expression of intermediate filaments and synaptophysin show neuronal properties and lack of glial characteristics in Y79 retinoblastoma cells.中间丝和突触素的表达显示Y79视网膜母细胞瘤细胞具有神经元特性且缺乏神经胶质细胞特征。
Lab Invest. 1988 Nov;59(5):649-56.

引用本文的文献

1
Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.
Br J Cancer. 1995 Mar;71(3):505-11. doi: 10.1038/bjc.1995.101.